Twist Bioscience stock jumps 2.86 percent as MRD advances spotlighted by Twist Bioscience

Traders Union
All News
Companies
Twist Bioscience rises 2.86% today

Highlights

TWST maintains a strong bullish structure across short, medium, and long-term timeframes, trading well above key moving averages.
Momentum and trend indicators confirm a robust ongoing uptrend, but overbought readings suggest buyers may be losing steam near resistance.
Expected range for the coming week is $76.20 to $80.10, with a high probability of consolidation near recent highs and limited downside risk.

Bullish structure persists as support forms above key moving averages

TWST is trading well above its MA-20 ($64.90), MA-50 ($59.79), and MA-200 ($42.04), underlining a robust bullish structure across short-, medium-, and long-term timeframes. The Ichimoku Kijun on D1 is at $64.27, which is below the current price and serves as immediate support.

Momentum strong but overbought readings risk waning rally strength

Momentum remains strongly positive on D1, with both MACD and ADX signaling an ongoing uptrend. RSI and CCI on D1 are approaching or within overbought territory, while Stoch RSI and BBP indicate that buyers continue to dominate, though with some signs of exhaustion. In today's session, TWST is up 2.86% as buyers push the price to the top of the weekly range. The stock has gained $6.95 or 10.04% from last week’s close at $69.22, and price action sits effectively at the very top of the weekly band, with volatility reaching 17.84%. This weekly move confirms a strong recovery from lower levels, but overbought indicator readings and the current position near resistance suggest the rally may be losing momentum.

Upside favored as technicals limit reversal risk near annual highs

For the coming week, the expected range is $76.20 to $80.10, close to the 52-week high of $80.50 and well above the 52-week low of $23.30. The probability of a price increase is very high (more than 80%) given all four W1 indicators (RSI, ADX, MACD, MA-50) are on Buy. There is a very low probability (less than 20%) of a significant decline. The baseline scenario sees the price consolidating near current levels in a sideways band. A bullish scenario would involve a clear breakout above $78.28, potentially challenging the yearly high. A bearish reversal could develop if the price falls below immediate support at $64.90, but with strong upward momentum, this appears less likely in the short-term.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Twist Bioscience was maintaining a broadly bullish structure, with technical signals favoring consolidation following strong gains. This article examines fresh developments and short-term catalysts, highlighting a key level that traders should monitor for signs of renewed momentum or potential reversal.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.